Physician profile
Lee E Ackley
NPI 1417933813
$865.48
in general payments reported to CMS, 2019-2025
16 companies · $393 in 2025
The $393 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $456 · 2022: $16.39 · 2025: $393.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $393.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $393.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $241.76 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $98.47 | 2021-2025 | Mounjaro, Zepbound |
| Glaxosmithkline, LLC. | $94.96 | 2021-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Pfizer INC. | $94.62 | 2021-2025 | |
| Sanofi-Aventis U.S. LLC | $50.53 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $49.45 | 2025 | |
| Biohaven Pharmaceuticals, INC. | $30.68 | 2021 | |
| Novartis Pharmaceuticals Corporation | $30.66 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.41 | 2021 | |
| Merck Sharp & Dohme LLC | $28.68 | 2021 | |
| Abbvie INC. | $28.44 | 2021-2022 | |
| Amarin Pharma, INC. | $24.11 | 2021 | |
| Dexcom, INC. | $19.05 | 2025 | Dexcom G6 Transmitter |
| Phathom Pharmaceuticals, INC. | $16.03 | 2025 | Voquezna |
| Astrazeneca Pharmaceuticals Lp | $14.17 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $13.46 | 2025 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lee Ackley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.